© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
A pair of studies found that bacteriophage therapy may treat alcoholic hepatitis and primary sclerosing cholangitis.
In a Phase IIa trial, the drug DUR-928 was associated with numerous positive outcomes after 28 days.
From fatty liver disease to cirrhosis to alcoholic hepatitis—here’s what you need to know.
If you want a healthy liver but you drink, you may want to read this.
Observing Alcohol Awareness Month with a look at alcoholic liver disease and drinking.
Among heavy drinkers, those in a recent study who drank coffee regularly had a lower rate of the liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
